WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007081760) HEMOSTATIC AGENT DELIVERY SYSTEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/081760    International Application No.:    PCT/US2007/000206
Publication Date: 19.07.2007 International Filing Date: 04.01.2007
Chapter 2 Demand Filed:    16.07.2007    
IPC:
A61F 13/20 (2006.01), A61F 13/00 (2006.01)
Applicants: MENTKOW, Jack [US/US]; (US).
MENTKOW, Lisa [US/US]; (US)
Inventors: MENTKOW, Jack; (US).
MENTKOW, Lisa; (US)
Agent: FULTON, John., Jr.; Malloy & Malloy, P.A., 2800 S.W. Third Avenue, Miami, FL 33129 (US)
Priority Data:
60/757,459 09.01.2006 US
11/453,524 15.06.2006 US
Title (EN) HEMOSTATIC AGENT DELIVERY SYSTEM
(FR) SYSTÈME D’ADMINISTRATION D’AGENT HÉMOSTATIQUE
Abstract: front page image
(EN)A hemostatic agent delivery system includes a hemostatic agent which is inert and non-reactive yet is capable of forming a stable clot when applied to an actively bleeding wound. The system also includes a delivery assembly to structure to facilitate delivery of the hemostatic agent proximate the hemorrhage site. More specifically, the delivery assembly is structured to releasably contain the hemostatic agent via a release member which is disposed in cooperative relation with a support member which contains the amount of the hemostatic agent. The release member is structured of a soluble material such that it will at least partially dissolve and release the hemostatic agent upon disposition proximate the hemorrhage site. The delivery assembly further comprises a handle member structured to facilitate delivery of the hemostatic agent to the hemorrhage site .
(FR)Un système d’administration d’agent hémostatique contient un agent hémostatique qui est inerte et non réactif mais est capable de former un caillot stable une fois appliqué à une bobiné de saignement actif. Le système comporte également un ensemble d’administration vers une structure pour faciliter l’administration de l’agent hémostatique proche du site d’hémorragie. Plus spécifiquement, l’ensemble d’administration est structuré pour contenir de manière libérable l’agent hémostatique par le biais d’un élément de libération qui se trouve en coopération avec un élément support contenant la quantité de l’agent hémostatique. L’élément de libération est constitué d’un matériau soluble de telle sorte qu’il va au moins partiellement dissoudre et libérer l’agent hémostatique en cas de disposition près du site d’hémorragie. L’ensemble d’administration comporte également un élément à poignée structuré pour faciliter l’administration de l’agent hémostatique au site d’hémorragie.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)